Caveolin-1 is a principal component of caveolae membranes in vivo. Caveolin
-1 mRNA and protein expression are down-regulated in NIH 3T3 cells in respo
nse to transformation by activated oncogenes, such as H-Ras(G12V) and v-Abl
, The mechanisms governing this down-regulation event remain unknown. Here,
we show that caveolin-1 gene expression is directly regulated by activatio
n of the Ras-p42/44 MAP kinase cascade, Down regulation of caveolin-1 prote
in expression by Ras is independent of (i) the type of activating mutation
(G12V versus Q61L) and (ii) the form of activated Ras transfected (H-Ras ve
rsus H-Ras versus N-Ras), Treatment of Ras or Raf-transformed MH 3T3 cells
with a well characterized MEK inhibitor (PD 98059) restores caveolin-1 prot
ein expression. In contrast, treatment of v-Src and v-Abl transformed NIH 3
T3 cells with PD 98059 does not restore caveolin-1 expression. Thus, there
must be at least two pathways for down-regulating caveolin-1 expression: on
e that is p42/44 MAP kinase-dependent and another that is p42/44 MAP kinase
-independent. We focused our efforts on the p42/44 MAP kinase-dependent pat
hway. The activity of a panel of caveolin-1 promoter constructs was evaluat
ed using transient expression in H-Ras(G12V) transformed MR 3T3 cells. We s
how that caveolin-1 promoter activity is up-regulated similar to 5-fold by
inhibition of the p42/44 MAP kinase cascade. Using electrophoretic mobility
shift assays we provide evidence that the caveolin-1 promoter (from -156 t
o -561) is differentially bound by transcription factors in normal and H-Ra
s(G12V)-transformed cells. We also show that activation of protein kinase A
(PKA) signaling is sufficient to down-regulate caveolin-1 protein expressi
on and promoter activity. Thus, we have identified two signaling pathways (
Ras-p42/44MAP kinase and PKA) that transcriptionally down-regulate caveolin
-1 gene expression.